Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy

Stefano Alivernini, Elisa Gremese, Francesco Conti, Gianfranco Ferraccioli, R Caporali, F Atzeni, B Seriolo, M Cutolo, G Valesini, P Sarzi Puttini, C Salvarani, S Guiducci, G Zampogna, N Pipitone, R Scrivo, S Bugatti, C Montecucco, M. Matucci Cerinic

Risultato della ricerca: Contributo in rivistaArticolo in rivista

33 Citazioni (Scopus)

Abstract

Given the availability of novel biologic agents for the treatment of rheumatoid arthritis (RA), various national scientific societies have developed specific recommendations in order to assist rheumatologists in prescribing these drugs. The Italian Society for Rheumatology (Società Italiana di Reumatologia, SIR) decided to update its recommendations and, to this end, a systematic literature review was carried out and the evidence derived from it was discussed and summarised as expert opinions. Levels of evidence, strength of recommendations and levels of agreement were reported. The recommendations reported are intended to help prescribing rheumatologists to optimise the use of biologic agents in patients with RA seen in everyday practice; they are not to be considered as a regulatory rule.
Lingua originaleEnglish
pagine (da-a)S7-S14
RivistaCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Volume29
Stato di pubblicazionePubblicato - 2011

Keywords

  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Biological Agents
  • Biological Therapy
  • Evidence-Based Medicine
  • Humans
  • Italy
  • Patient Selection
  • Rheumatology
  • Societies, Medical
  • Treatment Outcome

Fingerprint

Entra nei temi di ricerca di 'Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy'. Insieme formano una fingerprint unica.

Cita questo